Foamix Pharmaceuticals Ltd. Shareholders' Equity
Foamix Pharmaceuticals Ltd. had Shareholders' Equity of $17.57 million as of 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2020-03-12
- 2019-12-31: Stockholders' Equity Attributable to Parent $17.57M.
- 2019-09-30: Stockholders' Equity Attributable to Parent $53.53M.
- 2019-06-30: Stockholders' Equity Attributable to Parent $60.38M.
- 2019-03-31: Stockholders' Equity Attributable to Parent $78.00M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2019-12-31 | $17.57M 10-K · filed 2020-03-12 |
| 2019-09-30 | $53.53M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $60.38M 10-Q · filed 2019-11-12 |
| 2019-03-31 | $78.00M 10-Q · filed 2019-08-07 |
| 2018-12-31 | $92.18M 10-K · filed 2020-03-12 |
| 2018-09-30 | $105.06M 10-Q · filed 2019-11-12 |
| 2018-06-30 | $43.90M 10-Q · filed 2019-11-12 |
| 2018-03-31 | $44.34M 10-Q · filed 2019-08-07 |
| 2017-12-31 | $68.60M 10-K · filed 2020-03-12 |
| 2017-06-30 | $100.90M 6-K · filed 2017-08-08 |
| 2016-12-31 | $129.99M 10-K · filed 2020-03-12 |
| 2016-06-30 | $89.52M 6-K · filed 2017-08-08 |
| 2015-12-31 | $100.80M 10-K · filed 2019-02-28 |
| 2015-06-30 | $108.68M 6-K · filed 2016-08-10 |
| 2014-12-31 | $48.76M 10-K · filed 2018-03-01 |
| 2014-06-30 | -$6.20M 6-K · filed 2015-10-19 |
| 2013-12-31 | -$3.58M 20-F · filed 2017-02-21 |
| 2012-12-31 | -$2.94M 20-F · filed 2016-03-02 |
| 2011-12-31 | -$2.29M 20-F · filed 2015-03-17 |